Harmony Biosciences Holdings, Inc. — insider transactions

23 transactions on record · HRMY · CIK 1802665

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
23
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
1
Bought, 3m
$0
Sold, 3m
$5M
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$1.5M
2026-09-18
Director share, 12m
0.0%
of transactions where role is stated
Current run
23 sells
consecutive same-direction transactions
Net 3m flow
-$5M
purchases minus sales
Total on record
23

Transactions

23 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-09-182026-09-162Budur KumarCHIEF MEDICAL OFFICEROpen market sale1,800$43.01$77.4Kfiling
2026-09-182026-09-171Budur KumarCHIEF MEDICAL OFFICEROpen market sale800$43.00$34.4Kfiling
2026-09-182026-09-180Budur KumarCHIEF MEDICAL OFFICEROpen market sale35,852$43.05$1.5Mfiling
2026-09-182026-09-171Budur KumarCHIEF MEDICAL OFFICERExercise of derivative400$0.00—filing
2026-09-182026-09-162Budur KumarCHIEF MEDICAL OFFICERExercise of derivative900$30.69$27.6Kfiling
2026-09-182026-09-171Budur KumarCHIEF MEDICAL OFFICERExercise of derivative400$30.69$12.3Kfiling
2026-09-182026-09-180Budur KumarCHIEF MEDICAL OFFICERExercise of derivative10,406$30.69$319.4Kfiling
2026-09-182026-09-162Budur KumarCHIEF MEDICAL OFFICERExercise of derivative900$30.27$27.2Kfiling
2026-09-182026-09-171Budur KumarCHIEF MEDICAL OFFICERExercise of derivative400$30.27$12.1Kfiling
2026-09-182026-09-180Budur KumarCHIEF MEDICAL OFFICERExercise of derivative25,446$30.27$770.3Kfiling
2026-09-182026-09-162Budur KumarCHIEF MEDICAL OFFICERExercise of derivative900$0.00—filing
2026-09-182026-09-180Budur KumarCHIEF MEDICAL OFFICERExercise of derivative10,406$0.00—filing
2026-09-182026-09-162Budur KumarCHIEF MEDICAL OFFICERExercise of derivative900$0.00—filing
2026-09-182026-09-171Budur KumarCHIEF MEDICAL OFFICERExercise of derivative400$0.00—filing
2026-09-182026-09-180Budur KumarCHIEF MEDICAL OFFICERExercise of derivative25,446$0.00—filing
2026-09-092026-09-081Budur KumarCHIEF MEDICAL OFFICEROpen market sale1,000$42.79$42.8Kfiling
2026-09-092026-09-081Budur KumarCHIEF MEDICAL OFFICEROpen market sale22,954$43.10$989.3Kfiling
2026-09-092026-09-081Budur KumarCHIEF MEDICAL OFFICEROpen market sale4,500$42.25$190.1Kfiling
2026-09-092026-09-081Budur KumarCHIEF MEDICAL OFFICERExercise of derivative10,754$30.27$325.5Kfiling
2026-09-092026-09-081Budur KumarCHIEF MEDICAL OFFICERExercise of derivative10,754$0.00—filing
2026-09-092026-09-045Budur KumarCHIEF MEDICAL OFFICEROpen market sale5,500$41.98$230.9Kfiling
2026-09-092026-09-081Budur KumarCHIEF MEDICAL OFFICERExercise of derivative12,200$30.69$374.4Kfiling
2026-09-092026-09-081Budur KumarCHIEF MEDICAL OFFICERExercise of derivative12,200$0.00—filing

Source: U.S. Securities and Exchange Commission, EDGAR

Harmony Biosciences Holdings, Inc. insider transactions — 23 filings on record — investment.com